Abstract
Harm reduction is often defined as value-neutral with regard to drug use and drug users. In this paper Fry, Treloar & Maher argue that to its detriment, harm reduction research (and practice), in its focus on technical skills, evidence and innovation, has failed to articulate an agreed moral framework. Using case examples from a recent forum on the topic, they make a case for a more ethically engaged harm reduction. Recent debate about ethical issues within harm reduction occurs against similar discussion in public health. The authors explain that crucial issues emerge at intersections between human rights, consumer engagement and applied communitarian ethics.Simon Lenton Editor, Harm Reduction Digest
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.